pembrolizumab,docetaxel
merck
['neopact']
neopact supports less chemo in neoadjuvant setting and highlights immunotherapy benefits in borderline hr positive bc #asco22 in practice we had patients achieve pcr after only 4 cycles. 
Regional Cancer Research Director @CleveClinicFl #Scientist #Immune #Oncology #Epigenetics #Cancer #Sensitisation #TIME #StayPositive. Tweets are mine.